세계의 세포 동결보존 시장 보고서(2025년)
Cell Cryopreservation Global Market Report 2025
상품코드 : 1825654
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세포 동결보존 시장 규모는 향후 몇 년 동안 비약적인 성장이 예상됩니다. 2029년에는 CAGR 22.5%로 353억 달러로 성장할 전망입니다. 예측 기간의 성장은 체외수정(IVF) 시술에 대한 수요 증가, 장기 이식 시술의 발전, 바이오 뱅킹 활동의 확대, 만성 질환의 유병률 증가, 정부의 적극적인 노력과 자금 지원 등에 기인하는 것으로 보입니다. 예측 기간의 주요 동향으로는 냉동 보존 기술의 발전, mRNA 백신의 보존 및 수송의 발전, 동결 보호제 및 냉동 기술의 발전, 개인 맞춤형 의료 경향 증가, 줄기세포 연구의 발전 등을 꼽을 수 있습니다.

향후 5년간 22.5%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 이탈리아나 스위스에서 개발된 프로그램 가능한 동결 시스템이나 GMP(Good Manufacturing Practice) 등급의 동결보호제 가격이 급등하여 세포의 생존율을 떨어뜨리고 귀중한 임상 샘플의 보관비용이 상승하여 미국의 바이오뱅크 사업을 저해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

세포 동결보존 시장의 성장은 장기 이식 수술 증가에 의해 견인될 것으로 예측됩니다. 장기이식은 손상되거나 기능부전에 빠진 장기를 기증자로부터 얻은 건강한 장기와 교환하는 것으로, 유전적 이상, 감염, 외상, 만성질환 등 다양한 원인에 의한 장기부전 등의 요인으로 인해 증가 추세에 있습니다. 장기 이식에서 세포 동결보존은 장기 세포를 동결보존하여 향후 사용을 위해 생존력을 유지하고, 이식 성공률을 높이고, 면역 거부반응을 감소시키는 중요한 역할을 합니다. 예를 들어, 2024년 1월 Health Resources and Services Administration이 발표한 데이터에 따르면 2023년 장기 이식은 이전보다 크게 증가하여 세포 동결보존에 대한 수요를 촉진하는 장기 이식 증가 추세를 강조하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Cell cryopreservation involves cooling cells to sub-zero temperatures, typically in liquid nitrogen at -196°C, to preserve them. This process stops all biological activity and metabolism, enabling cells to be stored for extended periods without deterioration. Cryoprotective agents are essential to prevent ice crystal formation, which could harm cell structures during freezing and thawing.

The primary products of cell cryopreservation include cell freezing media, equipment, and consumables. Equipment comprises specialized tools such as controlled-rate freezing apparatuses or isopropanol chambers designed to freeze cells at specific rates. This technology finds applications in preserving various cell types such as hepatocytes, stem cells, oocytes, embryotic cells, sperm cells, among others. These products reach end-users through channels such as biopharmaceutical and pharmaceutical companies, research institutes, Biobanks, in vitro fertilization (IVF) clinics, and similar entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cell cryopreservation market research report is one of a series of new reports from The Business Research Company that provides cell cryopreservation market statistics, including the cell cryopreservation industry global market size, regional shares, competitors with cell cryopreservation market share, detailed cell cryopreservation market segments, market trends, and opportunities, and any further data you may need to thrive in the cell cryopreservation industry. These cell cryopreservation market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell cryopreservation market size has grown exponentially in recent years. It will grow from $12.65 billion in 2024 to $15.68 billion in 2025 at a compound annual growth rate (CAGR) of 24.0%. The growth in the historic period can be attributed to increasing demand for cell-based therapies, rise in biomedical research, growing need for organ transplantation, rise in R&D activities for cell based therapies and increasing use of cryopreserved cell.

The cell cryopreservation market size is expected to see exponential growth in the next few years. It will grow to $35.3 billion in 2029 at a compound annual growth rate (CAGR) of 22.5%. The growth in the forecast period can be attributed to rising demand for in vitro fertilization (IVF) procedures, advancement in organ transplantation procedures, expansion of biobanking activities, rising incidence of chronic diseases and positive government initiatives and funding. Major trends in the forecast period include advancements in cryopreservation techniques, advancements in MRNA vaccine storage and transportation, advancements in cryoprotectants and freezing techniques, growing trend towards personalized medicine and advancements in stem cell research.

The forecast of 22.5% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. biobanking by inflating prices of programmable freezing systems and Good Manufacturing Practices(GMP)-grade cryoprotectants developed in Italy and Switzerland, resulting in reduced cell viability and higher storage costs for precious clinical samples. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growth of the cell cryopreservation market is anticipated to be driven by the increasing number of organ transplantation procedures. Organ transplantation involves replacing damaged or failing organs with healthy ones from donors, a procedure on the rise due to factors such as organ failure from various causes such as hereditary abnormalities, infections, traumas, and chronic diseases. In the context of organ transplantation, cell cryopreservation plays a vital role by freezing and storing cells from organs, preserving their viability for future use, improving graft success rates, and reducing immune rejection. For instance, data from the Health Resources and Services Administration in January 2024 showed a significant increase in organ transplants performed in 2023 compared to previous years, highlighting the upward trend in organ transplantation that fuels the demand for cell cryopreservation.

Companies in the cell cryopreservation market are focusing on developing advanced cryopreservation medium solutions to meet evolving customer needs. Cryopreservation medium solutions are specialized formulations that freeze cells or tissues at ultra-low temperatures, enabling long-term storage and transport while maintaining their viability and functionality. For example, Pluristyx Inc., a US-based provider of tools and technologies for cellular therapies, recently introduced PluriFreeze, a proprietary cryopreservation medium solution designed to accelerate the development of stem cell therapies. PluriFreeze is specifically tailored to support the growth of induced pluripotent stem cells (iPSCs), offering a novel approach to enhance the efficiency and quality of iPSC therapy development, particularly in stem cell therapy research and commercialization.

In January 2022, Cryoport, Inc., a management consulting services firm located in the US, joined forces with Cell Matters S.A. to offer comprehensive cryopreservation solutions for both autologous and allogeneic leukapheresis-based cell therapies. This collaboration aims to provide the life sciences sector with complete, end-to-end cryopreservation services, improving the consistency and quality of therapies derived from leukapheresis for both types of cell therapies. Cell Matters S.A., based in Belgium, specializes in cryobiology, cell therapy production, and cryopreservation techniques.

Major companies operating in the cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Corning Inc., STEMCELL Technologies, Cryoport Inc., BioLife Solutions Inc, Nkarta Inc., Tn-Sanso Corporation, Coya Therapeutics, FUJIFILM Irvine Scientific, Artiva Biotherapeutics, Acorn Biolabs Inc., ThermoGenesis Holdings Inc., Evia Bio Inc., Wideblue Limited, Akron Biotech, Captivate Bio LLC, Pluristyx Inc., CryoCrate LLC, PanTHERA CryoSolutions, ParaTechs Corporation, Plus Therapeutics, X-Therma Inc., Protein Technologies Limited

North America was the largest region in the cell cryopreservation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell cryopreservation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cell cryopreservation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell cryopreservation market consists of sales of cryoprotectants, freezing containers, and cryogenic storage systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Cryopreservation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell cryopreservation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cell cryopreservation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cell cryopreservation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cell Cryopreservation Market Characteristics

3. Cell Cryopreservation Market Trends And Strategies

4. Cell Cryopreservation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cell Cryopreservation Growth Analysis And Strategic Analysis Framework

6. Cell Cryopreservation Market Segmentation

7. Cell Cryopreservation Market Regional And Country Analysis

8. Asia-Pacific Cell Cryopreservation Market

9. China Cell Cryopreservation Market

10. India Cell Cryopreservation Market

11. Japan Cell Cryopreservation Market

12. Australia Cell Cryopreservation Market

13. Indonesia Cell Cryopreservation Market

14. South Korea Cell Cryopreservation Market

15. Western Europe Cell Cryopreservation Market

16. UK Cell Cryopreservation Market

17. Germany Cell Cryopreservation Market

18. France Cell Cryopreservation Market

19. Italy Cell Cryopreservation Market

20. Spain Cell Cryopreservation Market

21. Eastern Europe Cell Cryopreservation Market

22. Russia Cell Cryopreservation Market

23. North America Cell Cryopreservation Market

24. USA Cell Cryopreservation Market

25. Canada Cell Cryopreservation Market

26. South America Cell Cryopreservation Market

27. Brazil Cell Cryopreservation Market

28. Middle East Cell Cryopreservation Market

29. Africa Cell Cryopreservation Market

30. Cell Cryopreservation Market Competitive Landscape And Company Profiles

31. Cell Cryopreservation Market Other Major And Innovative Companies

32. Global Cell Cryopreservation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell Cryopreservation Market

34. Recent Developments In The Cell Cryopreservation Market

35. Cell Cryopreservation Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기